Parnassus Endeavor Fund BSX trades
Parnassus Investments
Parnassus Endeavor Fund Boston Scientific Corp stake
total: 120
Trades details
- Total transactions:
- 3
- New positions:
- 1
- Added:
- 2
- Held since:
- 2026 Q1
- Held for:
- 3 quarters
- Latest activity:
- 2026 Q3
According to 2026 Q3 report, Parnassus Endeavor Fund holds 1,535,354 Boston Scientific Corp (BSX) shares with a market value of roughly $67.02M accounting for 1.31% of the overall portfolio. To date, the estimated cost basis is nearly $51.77 for "buy" trades. Parnassus Endeavor Fund first purchased BSX in 2026 Q1, initially acquiring 678,208 shares. Since the initial investment in Boston Scientific Corp (BSX), Parnassus Endeavor Fund has made 2 more transactions.
When did Parnassus Endeavor Fund buy Boston Scientific Corp (BSX)?
Parnassus Endeavor Fund first invested in Boston Scientific Corp (BSX) in 2026 Q1 at the reported quarter-end price of $62.75 per share.
What's the cost basis of Parnassus Endeavor Fund's BSX stake?
The estimated cost basis for Boston Scientific Corp (BSX) stake is around $51.77 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $51.77
Parnassus Endeavor Fund's historical trades in Boston Scientific Corp
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
1.31%
|
1,535,354
|
$43.65
|
$67,018,202
|
+30.69% (+360,555)
|
+0.31%
|
|
2026 Q2
|
0.95%
|
1,174,799
|
$42.68
|
$50,140,421
|
+73.22% (+496,591)
|
+0.4%
|
|
2026 Q1
|
0.92%
|
678,208
|
$62.75
|
$42,557,552
|
new
|
+0.92%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.